News: Research

The anthrax antitoxin obiltoxaximab received approval March 21 from the U.S. Food and Drug Administration (FDA).

The University of Texas at Austin's Emily Que, an assistant professor of chemistry, was lead author on a new study that describes the cutting-edge technology a research team used to become the first to capture images of these molecular fireworks and to pinpoint the origin of the zinc sparks.

Researchers from The University of Texas at Austin and five other institutions have created a molecule that can cause cancer cells to self-destruct by ferrying sodium and chloride ions into the cancer cells.